We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eirx Therap. | LSE:ERX | London | Ordinary Share | GB00B0XQBS97 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.015 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 4893Y EiRx Therapeutics PLC 07 July 2008 Financial Services Authority TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or Eirx Therapeutics Plc the underlying issuer of existing shares to which voting rights are attached ii: 2. Reason for notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights Yes An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Yes Other (please specify): Barclays PLC 3. Full name of person(s) subject to the notification obligation iii: 4. Full name of shareholder(s) (if different from 3): Barclays Stockbrokers Ltd 04-Jul-08 5. Date of transaction and date on which the threshold is crossed or reached v: 07-Jul-08 6. Date on which issuer notified: 6% to 5% 7. Threshold(s) that is/are crossed or reached: 8. Notified details: A: Voting rights attached to shares Class/type Situation Resulting situation after the triggering transaction vii of shares previous to the Triggering transaction vi if possible using the ISIN CODE Number Number Number Number of Voting Rights % of voting Of Of Of rights Shares Voting Rights viii Shares Direct x Indirect xi Direct Indirect GB00B0XQBS97 462,276,969 462,276,969 458,922,775 0 458,922,775 0.00 5.37 B: Financial Instruments Resulting situation after the triggering transaction xii Type of financial instrument Expiration Exercise/Conversion No. of voting Percentage of voting date xiii Period/Date xiv rights that may be rights acquired if the instrument exercised/converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights Percentage of voting rights 458,922,775 5.37 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable xv : Barclays Stockbrokers Ltd Proxy Voting: 10. Name of proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: N/A 14. Contact name: Geoff Smith 15. Contact telephone number 020 7116 2913 This information is provided by RNS The company news service from the London Stock Exchange END HOLUBUSRWKRBRAR
1 Year Eirx Therapeutics Chart |
1 Month Eirx Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions